Estimating the Treatment Effect in a Clinical Trial Using Difference in Restricted Mean Survival Time
- 1 December 2015
- journal article
- research article
- Published by SAGE Publications in The Stata Journal: Promoting communications on statistics and Stata
- Vol. 15 (4) , 1098-1117
Abstract
The causal effect of a new medical treatment compared with a standard regimen is best assessed in a randomized controlled trial setting. When the main outcome is time to some event of interest, such as death, studies often use the hazard ratio to describe the treatment effect. Typically, proportional hazards are assumed. Here I discuss several significant disadvantages of using the hazard ratio, including its vulnerability to the proportionality assumption, its relative nature, and its lack of relationship with time-to-event or survival probabilities. I describe the use of restricted mean survival time as an alternative outcome measure in time-to-event trials. With this method, the treatment effect is defined as the difference in restricted mean between the trial arms. I suggest the use of Royston and Parmar's (2002, Statistics in Medicine 21: 2175–2197) class of flexible parametric models, implemented through the command stpm2 (Lambert and Royston [2009, Stata Journal 9: 265–290] and Andersson and Lambert [2012, Stata Journal 12: 623–638]), to estimate the required quantities. With this approach, proportional hazards are not assumed. I describe a new command, strmst, for implementing these calculations. This method supports “direct” adjustment for covariates by using marginalization over their observed distribution, and it supports estimation of treatment effects conditional on fixed values of covariates. I illustrate the methodology using data from a trial in primary biliary cirrhosis. I provide an example that demonstrates the importance of understanding the relationship between the treatment effect, the prognosis of the disease outcome, and the often-neglected time domain.Keywords
This publication has 14 references indexed in Scilit:
- Regression Analysis of Censored Data Using Pseudo-observations: An UpdateThe Stata Journal: Promoting communications on statistics and Stata, 2015
- Fitting and Modeling Cure in Population-Based Cancer Studies within the Framework of Flexible Parametric Survival ModelsThe Stata Journal: Promoting communications on statistics and Stata, 2012
- Regression Analysis of Censored Data Using Pseudo-observationsThe Stata Journal: Promoting communications on statistics and Stata, 2010
- Pseudo-observations in survival analysisStatistical Methods in Medical Research, 2009
- Further Development of Flexible Parametric Models for Survival AnalysisThe Stata Journal: Promoting communications on statistics and Stata, 2009
- Dichotomizing continuous predictors in multiple regression: a bad ideaStatistics in Medicine, 2005
- Regression Analysis of Restricted Mean Survival Time Based on Pseudo-ObservationsLifetime Data Analysis, 2004
- Model Selection: An Integral Part of Inference1997
- Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosisGastroenterology, 1985
- The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with miceEpidemiology and Infection, 1949